Clinical Trial Update: Immunostimulatory CpG SD-101 + RT in Recurrent/Progressive Lymphoma After Allogeneic Hematopoietic Cell Transplantation (HCT) [Phase 1]

View source ↗

Summary

Phase 1 trial update of immunostimulatory CpG SD-101 plus radiation therapy for recurrent/progressive lymphoma after allogeneic hematopoietic cell transplantati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• SD-101

Snippet

Sponsor: Robert Lowsky | Conditions: Lymphoma, Non-Hodgkin, Hodgkin Disease | Phase 1 | Status: TERMINATED